Estados financieros detallados de MDxHealth S.A. (MDXH): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
MDxHealth S.A. registró ingresos de $107.9M en el último ejercicio fiscal, con un CAGR de 5 años del 42.3%.
Márgenes de los últimos 12 meses: margen bruto 57.7%, margen operativo -16.6%, margen neto -32.2%.
Al precio actual de $0.68, MDXH presenta beneficios negativos (P/E no significativo) y un ROE del 402.97%. La capitalización bursátil es de $35M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $29.9M | $40.5M | $28.3M | $11.8M | $18.5M | $22.2M | $37.1M | $70.2M | $90.0M | $107.9M |
| Coste de Ventas | $10.1M | $10.2M | $11.7M | $11.9M | $10.4M | $11.7M | $17.8M | $26.3M | $34.9M | $43.4M |
| Beneficio Bruto | $19.8M | $30.3M | $16.7M | -$144000 | $8.0M | $10.6M | $19.2M | $43.9M | $55.1M | $64.4M |
| I+D | -$332000 | $1.8M | $1.8M | $9.0M | $4.5M | $5.6M | $7.6M | $6.4M | $10.6M | $10.3M |
| Generales y Administrativos | $11.6M | $13.5M | $15.3M | $10.1M | $28.6M | $30.2M | $50.1M | $59.9M | $61.4M | $66.8M |
| Gastos Operativos | $32.6M | $42.6M | $48.8M | $43.0M | $35.2M | $37.4M | $57.1M | $71.3M | $79.9M | $79.8M |
| Beneficio Operativo | -$12.8M | -$12.3M | -$32.1M | -$43.2M | -$27.1M | -$26.8M | -$37.9M | -$27.3M | -$24.7M | -$15.4M |
| EBITDA | -$11.6M | -$10.2M | -$29.5M | -$39.7M | -$24.0M | -$24.1M | -$36.4M | -$30.5M | -$22.0M | -$14.0M |
| Gastos por Intereses | 0 | $122000 | $82000 | $516000 | $1.5M | $1.9M | $2.7M | $5.8M | $7.6M | $12.2M |
| Beneficio Antes de Impuestos | -$13.3M | -$12.4M | -$32.5M | -$43.7M | -$28.7M | -$29.0M | -$44.0M | -$43.1M | -$37.7M | -$35.4M |
| Impuestos | -$113000 | -$113000 | -$41000 | -$575000 | 0 | 0 | 0 | $1000 | $382000 | -$1.9M |
| Beneficio Neto | -$13.2M | -$12.3M | -$32.5M | -$43.1M | -$28.7M | -$29.0M | -$44.0M | -$43.1M | -$38.1M | -$33.5M |
| BPA | $-2.86 | $-2.46 | $-5.63 | $-6.89 | $-3.44 | $-2.38 | $-2.78 | $-1.66 | $-0.78 | $-0.67 |
| BPA Diluido | $-2.86 | $-2.46 | $-5.63 | $-6.89 | $-3.44 | $-2.38 | $-2.78 | $-1.66 | $-1.16 | $-0.67 |
| Acciones en Circulación (Diluidas) | $4.6M | $5.0M | $5.8M | $6.3M | $8.3M | $12.2M | $15.9M | $25.9M | $48.7M | $50.0M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $30.5M | $16.8M | $26.2M | $22.1M | $16.0M | $58.5M | $15.5M | $22.4M | $46.8M | $29.0M |
| Inversiones a Corto | 0 | 0 | 0 | $51000 | 0 | $89000 | $101000 | 0 | 0 | 0 |
| Cuentas por Cobrar | $18.5M | $19.9M | $19.1M | $6.6M | $3.9M | $4.6M | $9.4M | $11.3M | $14.5M | $14.7M |
| Inventario | $1.5M | $1.9M | $1.8M | $1.2M | $2.3M | $1.9M | $2.3M | $2.8M | $3.9M | $6.7M |
| Activos Corrientes | $51.5M | $39.3M | $47.9M | $30.9M | $23.1M | $66.6M | $29.1M | $38.2M | $66.9M | $53.4M |
| Inmovilizado Material | $2.3M | $2.6M | $2.1M | $2.5M | $3.7M | $5.0M | $7.9M | $9.9M | $13.0M | $14.7M |
| Fondo de Comercio | $1.1M | $1.1M | $1.1M | 0 | 0 | 0 | $35.9M | $35.9M | $35.9M | $38.9M |
| Activos Intangibles | $12.8M | $15.5M | $14.4M | $7.3M | $5.1M | $3.4M | $46.2M | $44.3M | $40.6M | $39.4M |
| Activos Totales | $67.7M | $58.5M | $65.5M | $40.6M | $31.9M | $75.1M | $119.1M | $129.1M | $157.3M | $148.0M |
| Cuentas por Pagar | $7.5M | $8.1M | $6.5M | $5.0M | $5.3M | $7.5M | $10.2M | $8.8M | $8.0M | $10.3M |
| Deuda a Corto | $430000 | $191000 | $147000 | $565000 | $2.8M | $4.4M | $616000 | $643000 | $324000 | $1.9M |
| Pasivos Corrientes | $12.6M | $13.1M | $11.5M | $10.4M | $13.0M | $16.4M | $18.3M | $19.5M | $42.7M | $49.5M |
| Deuda a Largo | $108000 | $147000 | 0 | $9.1M | $10.3M | $7.7M | $34.9M | $35.6M | $51.0M | $84.7M |
| Pasivos Totales | $15.0M | $15.0M | $13.4M | $20.9M | $26.0M | $28.2M | $109.8M | $121.9M | $142.5M | $160.0M |
| Reservas | -$98.8M | -$111.1M | -$143.5M | -$186.6M | -$215.3M | -$244.3M | -$288.3M | -$331.4M | -$369.5M | -$403.0M |
| Patrimonio Neto | $52.7M | $43.5M | $52.1M | $19.7M | $5.8M | $46.9M | $9.3M | $7.2M | $14.8M | -$12.1M |
| Deuda Total | $538000 | $884000 | $526000 | $11.0M | $15.9M | $15.6M | $39.8M | $41.3M | $60.1M | $95.1M |
| Deuda Neta | -$30.0M | -$15.9M | -$25.7M | -$11.1M | -$82000 | -$43.0M | $24.2M | $18.9M | $13.3M | $66.1M |
| Capital Circulante | $38.9M | $26.2M | $36.4M | $20.5M | $10.1M | $50.2M | $10.9M | $18.6M | $24.2M | $3.9M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$12.8M | -$12.3M | -$32.1M | -$43.2M | -$27.1M | -$26.8M | -$37.9M | -$27.3M | -$24.7M | -$14.4M |
| Amortizaciones | $1.7M | $1.9M | $2.9M | $3.4M | $3.3M | $3.0M | $4.9M | $6.9M | $8.0M | $9.2M |
| Compensación en Acciones | $568000 | $943000 | $1.0M | $872000 | $1.3M | $1.2M | $867000 | $665000 | $1.7M | $2.2M |
| Cambio en Capital Circulante | -$6.1M | -$1.0M | -$291000 | $10.3M | $2.0M | $360000 | -$1.6M | -$2.1M | -$3.9M | $939000 |
| Flujo de Caja Operativo | -$16.6M | -$10.5M | -$28.5M | -$22.3M | -$20.2M | -$22.5M | -$34.1M | -$21.5M | -$18.5M | -$10.4M |
| Inversiones (CapEx) | -$4.9M | -$4.9M | -$1.3M | -$73000 | -$537000 | -$896000 | -$4.2M | -$5.0M | -$2.2M | -$1.2M |
| Adquisiciones | 0 | -$1.1M | 0 | 0 | 0 | 0 | -$25.0M | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$21.5M | -$15.3M | -$29.9M | -$22.4M | -$20.8M | -$23.4M | -$38.3M | -$26.5M | -$20.7M | -$11.6M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +35.6% | -30.0% | -58.4% | +56.6% | +20.5% | +66.6% | +89.4% | +28.3% | +19.8% | |
| Crecimiento Beneficio Neto (anual) | +6.7% | -164.1% | -32.8% | +33.5% | -1.2% | -51.9% | +2.1% | +11.7% | +12.0% | |
| Crecimiento BPA (anual) | +14.0% | -128.9% | -22.4% | +50.1% | +30.8% | -16.8% | +40.3% | +53.0% | +14.1% | |
| Cambio en Acciones (anual) | +8.3% | +15.4% | +8.6% | +32.9% | +46.6% | +30.1% | +63.3% | +87.8% | +2.8% | |
| Crecimiento FCF (anual) | +28.5% | -94.7% | +25.2% | +7.1% | -12.8% | -63.3% | +30.7% | +22.0% | +44.1% | |
| Margen Bruto | 66.2% | 74.8% | 58.9% | -1.2% | 43.6% | 47.5% | 51.9% | 62.6% | 61.2% | 59.7% |
| Margen Operativo | -43.0% | -30.3% | -113.3% | -366.3% | -146.9% | -120.7% | -102.3% | -38.9% | -27.5% | -14.3% |
| Margen EBITDA | -38.7% | -25.1% | -104.0% | -337.2% | -129.9% | -108.3% | -98.2% | -43.4% | -24.5% | -13.0% |
| Margen Neto | -44.1% | -30.3% | -114.5% | -365.7% | -155.3% | -130.4% | -118.9% | -61.4% | -42.3% | -31.1% |
| Margen FCF | -71.9% | -37.9% | -105.5% | -189.7% | -112.6% | -105.4% | -103.3% | -37.8% | -23.0% | -10.7% |
| Tasa Impositiva Efectiva | 0.9% | 0.9% | 0.1% | 1.3% | -0.0% | -0.0% | -0.0% | -0.0% | -1.0% | 5.2% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-4.66 | $-3.08 | $-5.19 | $-3.57 | $-2.50 | $-1.92 | $-2.41 | $-1.02 | $-0.43 | $-0.23 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $4.6M | $5.0M | $5.8M | $6.3M | $8.3M | $12.2M | $15.9M | $25.9M | $48.7M | $50.0M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | 402.97% |
| Rentabilidad sobre capital invertido | -12.74% |
| Rentabilidad sobre activos | -17.67% |
| Margen bruto | 57.68% |
| Margen operativo | -16.59% |
| Margen neto | -32.17% |
Salud financiera
| Deuda / Patrimonio | -7.86 |
| Ratio corriente | 1.08 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -2.73 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -4.20 | -4.88 | -2.13 | -1.74 | -3.49 | -4.00 | -2.38 | -2.37 | -3.04 | -5.33 |
| P/VC | 1.05 | 1.38 | 1.33 | 3.81 | 17.07 | 2.48 | 11.26 | 14.16 | 7.77 | -14.77 |
| P/V | 1.85 | 1.48 | 2.44 | 6.37 | 5.41 | 5.22 | 2.83 | 1.45 | 1.28 | 1.66 |
| Margen Bruto | 66.2% | 74.8% | 58.9% | -1.2% | 43.6% | 47.5% | 51.9% | 62.6% | 61.2% | 59.7% |
| Margen Operativo | -43.0% | -30.3% | -113.3% | -366.3% | -146.9% | -120.7% | -102.3% | -38.9% | -27.5% | -14.3% |
| Margen Neto | -44.1% | -30.3% | -114.5% | -365.7% | -155.3% | -130.4% | -118.9% | -61.4% | -42.3% | -31.1% |
Empresas relacionadas: ACRS · ASMB · IMRX · NEO · QTRX · SI · SNWV
Explorar sector: Healthcare · Medical - Diagnostics & Research
Más secciones de MDXH: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones